To build and maintain gold-standard, next generation R&D intelligence tools, Sitetrove, Trialtrove, Chinatrove, Pharmaprojects, and Trialpredict have been undergoing a major program of investment. In addition to the many new and exciting changes on the horizon, the robust and reliable Citeline tools that you use to inform your business decisions will formally join Informa’s Pharma Intelligence family of brands.
At Pharma Intelligence, the cutting-edge data, research, analysis, and forecasting you’ve come to expect from Informa’s global business intelligence brands are brought together into a single portfolio. This portfolio already includes Scrip, Pink Sheet, In Vivo, Datamonitor Healthcare, Biomedtracker, Medtrack, Strategic Transactions, Medtech Insight, Meddevicetracker and the recently launched Pharmapremia. In the coming months, you will notice the Pharma Intelligence brand name being used more frequently as the Citeline name will gradually be retired. We will be sharing more information over the next few months, and look forward to updating you as these changes occur.
Custom Subscriber URLs
For added security, access to Sitetrove, Trialtrove and Phrmaprojects services is provided via company specific URLs.
For example, if you are an employee of PharmaCoX, your company’s access would be via https://pharmacox.citeline.com. Please note that you must be on your company network in order to access our services as we are IP address authenticated.
Live and Pre-Recorded Training
Pharma Intelligence offers free and frequent introductory and advanced customized training sessions. In addition to live training, we have a library of pre-recorded sessions which you can review at your convenience. To inquire about upcoming dates, or to request a link to a recorded session, please contact your Account Manager or Client Services.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: